Read our insights and commentary about industry news and innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 5 of 30 posts
May 29, 2019 | Blog
Central Nervous System (CNS) Drug Development Strategy: What is the Role of External Investment in this High-Risk Disease Space?
PART I of CBPartners' CNS series: the concept of external investment may represent a positive trend in the neuroscience space where different size firms are focused on their comparative strengths.
May 28, 2019 | Videos
US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers which disease states are currently on their radar.
May 20, 2019 | Videos
US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers whether they think that innovative contracts will gain momentum in the future.
May 12, 2019 | Research posters
ISPOR International 2019: The Importance of Overall Survival as a Clinical Endpoint in FDA vs. EMA Regulatory Approval
ISPOR International 2019: CBPartners presented a poster about the importance of overall survival (OS) data as a clinical endpoint in FDA vs. EMA regulatory approval.
May 9, 2019 | Videos
US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers what they see the role of ICER being today, and becoming in the future.